• Jasplakinolide: Actin Polymerization Inducer

  2026-09-03

  Jasplakinolide is a membrane-permeable actin polymerization inducer that also stabilizes pre-existing F-actin. Its approximately 15 nM affinity in purified actin assays makes it a useful actin cytoskeleton research tool, while its fungicidal and antiproliferative activities require context-specific controls.

• In Vitro Drug Responses: Growth Inhibition vs Cell Death

  2026-09-03

  The dissertation by Hannah R. Schwartz separates relative viability from fractional viability to clarify how anticancer drugs combine proliferative arrest and cell killing. Its central finding is that most drugs affect both processes, but in different proportions and with different timing, making endpoint selection essential for interpreting in vitro drug responses.

• Dovitinib (TKI-258) RTK Signaling Workflows

  2026-09-02

  Dovitinib (TKI-258) provides a practical perturbation tool for mapping convergent RTK signaling, apoptosis induction, and treatment-response phenotypes across cancer models. This workflow connects its broad kinase coverage with the reference study’s ERK-centered melanoma findings while emphasizing controls that distinguish pathway inhibition from nonspecific cytotoxicity.

• Palonosetron Hydrochloride in Cell Assays

  2026-09-02

  This scenario-driven guide explains how Palonosetron hydrochloride (SKU B2229) can support selective 5-HT3 receptor studies, transporter inhibition experiments, and better interpretation of cell viability data. It connects quantitative assay ranges with practical preparation, controls, and evidence-based product-selection criteria.

• Cyanin Chloride in a HaCaT Psoriasis Model

  2026-09-01

  A 2024 study connected cyanin chloride treatment with reduced inflammatory signaling and improved barrier function in cytokine-stimulated HaCaT keratinocytes. Its value lies in combining antioxidant assays, macrophage inflammation testing, STAT3 analysis, cytokine profiling, TEER, and filaggrin measurements rather than relying on a single molecular endpoint.

• Streptavidin – FITC for Reliable Cell Assays

  2026-09-01

  Learn how Streptavidin – FITC (SKU K1081) supports biotin-based fluorescence readouts in cell viability, proliferation, cytotoxicity, imaging, and flow cytometry workflows. This scenario-driven guide explains assay design, spectral compatibility, protocol controls, interpretation limits, and practical vendor-selection criteria.

• Streptavidin-Cy3 Workflow for Biotin Detection

  2026-08-31

  Build brighter, more reproducible biotin-labeling assays for IHC, IF, ISH, and flow cytometry with a practical Streptavidin-Cy3 workflow. The guide also translates a recent biohybrid microrobot study into assay-design choices for mapping localization, barrier penetration, and tumor-spheroid interactions.

• Firefly Luciferase mRNA: Workflow & Troubleshooting

  2026-08-31

  Build more consistent gene expression, cell viability, and imaging assays with a capped, 5-methoxyuridine-modified reporter mRNA. This guide pairs practical optimization steps with a translational readout strategy inspired by pH-sensitive lipid nanoparticle protection research.

• Pharmacogenomics of Chloroquine and Hydroxychloroquine

  2026-08-30

  The 2023 review by Biswas and Sukasem synthesizes limited but clinically relevant evidence that CYP2C8, CYP3A4/5, and CYP2D6 variation may alter chloroquine and hydroxychloroquine exposure, efficacy, and toxicity. Its main contribution is a phenotype-based risk framework that highlights poor- and ultrarapid-metabolizer profiles while showing why prospective validation is still needed before routine genotype-guided treatment.

• Puromycin dihydrochloride: Selection & QC Guide

  2026-08-29

  Puromycin dihydrochloride is an aminonucleoside antibiotic used to select pac-expressing cell lines and to support controlled studies of translation and ribosome function. This guide explains dossier-based concentration, solubility, storage, and workflow considerations while identifying limits for transferring selection conditions to other cell types, organisms, or animal autophagy experiments.

• 7-Ethyl-10-hydroxycamptothecin: Assay Logic

  2026-08-28

  7-Ethyl-10-hydroxycamptothecin, also known as SN-38, is more than a cytotoxicity control. This article develops a decision-centered framework for connecting topoisomerase I trapping, FUBP1–FUSE biology, cell-cycle analysis, and apoptosis assays in advanced colon cancer research.

• 7-AAD Cell Viability Assay Kit for CAR-T Studies

  2026-08-28

  The 7-AAD Cell Viability Assay Kit provides a membrane-integrity endpoint for identifying necrotic and late apoptotic cells in flow cytometry and fluorescence microscopy. Its red-shifted fluorescence supports multiplex workflows with FITC, PE, APC, Calcein AM, and Annexin V markers.

• Rhodamine B for Responsive Nanomedicine Assays

  2026-08-27

  Rhodamine B can do more than label cells: it can serve as an optical measurement layer for studying targeted, enzyme-responsive nanomedicine. This article explains how to use Basic Violet 10 in assay design while avoiding the critical mistake of treating fluorescence intensity as direct evidence of drug release.

• Firefly Luciferase mRNA as a Delivery Stress Test

  2026-08-27

  Firefly Luciferase mRNA can do more than report gene expression: it can help separate delivery, stability, and translation effects. This guide connects 5-moUTP modified mRNA design with recent evidence on buffer-controlled LNP stabilization to improve assay interpretation.

• 2',7'-Dichlorofluorescein diacetate: ROS Assay Guide

  2026-08-26

  This scenario-based guide explains how 2',7'-Dichlorofluorescein diacetate, SKU C3381, supports reproducible intracellular ROS measurement across microscopy, flow cytometry, and plate-based workflows. It covers probe chemistry, preparation, controls, interpretation limits, and practical vendor-selection criteria for cell viability and cytotoxicity studies.

7775 records 1/519 page Next 12345 下5页 Last page